7-octadecynoic acid

7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.

Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid

MeSH term MeSH ID Detail
HIV Seropositivity D006679 15 associated lipids
Biliary Atresia D001656 4 associated lipids
Cachexia D002100 21 associated lipids
Addison Disease D000224 3 associated lipids
Primary Myelofibrosis D055728 6 associated lipids
Alveolar Bone Loss D016301 10 associated lipids
Periapical Periodontitis D010485 6 associated lipids
Vitamin D Deficiency D014808 13 associated lipids
Angina, Unstable D000789 14 associated lipids
Vascular Diseases D014652 16 associated lipids
Pregnancy Complications, Hematologic D011250 11 associated lipids
Periapical Diseases D010483 4 associated lipids
Albuminuria D000419 18 associated lipids
Lymphocytosis D008218 2 associated lipids
Heart Valve Diseases D006349 4 associated lipids
Measles D008457 3 associated lipids
Hyperinsulinism D006946 27 associated lipids
Scleroderma, Systemic D012595 16 associated lipids
Acromegaly D000172 6 associated lipids
Familial Mediterranean Fever D010505 12 associated lipids
Celiac Disease D002446 16 associated lipids
Carotid Stenosis D016893 15 associated lipids
Periapical Granuloma D010484 3 associated lipids
HIV Infections D015658 20 associated lipids
Graves Disease D006111 6 associated lipids
Synovitis D013585 15 associated lipids
Carcinoma, Papillary D002291 3 associated lipids
Carcinoma, Non-Small-Cell Lung D002289 72 associated lipids
Arthritis, Psoriatic D015535 3 associated lipids
Atrial Fibrillation D001281 16 associated lipids
Ventricular Dysfunction, Left D018487 33 associated lipids
Osteopetrosis D010022 1 associated lipids
Root Resorption D012391 2 associated lipids
Aortic Diseases D001018 11 associated lipids
Takayasu Arteritis D013625 3 associated lipids
Osteosclerosis D010026 2 associated lipids
Carcinoma, Neuroendocrine D018278 2 associated lipids
Hyperparathyroidism, Secondary D006962 4 associated lipids
Peripheral Vascular Diseases D016491 8 associated lipids
Sarcoma, Ewing D012512 2 associated lipids
Lymphatic Metastasis D008207 10 associated lipids
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative D054438 1 associated lipids
Actinobacillus Infections D000189 4 associated lipids
Prediabetic State D011236 1 associated lipids
Genetic Predisposition to Disease D020022 24 associated lipids
Aortic Aneurysm, Abdominal D017544 5 associated lipids
Hepatitis C D006526 7 associated lipids
Sclerosis D012598 5 associated lipids
Hyperostosis D015576 1 associated lipids
Legg-Calve-Perthes Disease D007873 1 associated lipids
Myositis, Inclusion Body D018979 3 associated lipids
Atherosclerosis D050197 85 associated lipids
Histiocytosis, Non-Langerhans-Cell D015616 4 associated lipids
Hearing Loss D034381 3 associated lipids
Musculoskeletal Diseases D009140 2 associated lipids
Histiocytosis, Langerhans-Cell D006646 1 associated lipids
Rupture, Spontaneous D012422 1 associated lipids
Bone Demineralization, Pathologic D018488 1 associated lipids
Temporomandibular Joint Disorders D013705 4 associated lipids
beta-Thalassemia D017086 5 associated lipids
Dilatation, Pathologic D004108 5 associated lipids
Radicular Cyst D011842 2 associated lipids
Ankylosis D000844 1 associated lipids
Multiple Sclerosis, Relapsing-Remitting D020529 7 associated lipids
Hyperparathyroidism D006961 3 associated lipids
Cholesteatoma, Middle Ear D018424 2 associated lipids
Neoplasms, Squamous Cell D018307 1 associated lipids
Metabolic Syndrome D024821 44 associated lipids
Giant Cell Tumor of Bone D018212 1 associated lipids
Jaw Diseases D007571 4 associated lipids
Ossification, Heterotopic D009999 2 associated lipids
Hypercalciuria D053565 4 associated lipids
Bone Marrow Neoplasms D019046 2 associated lipids
Eye Neoplasms D005134 2 associated lipids
Diabetes, Gestational D016640 8 associated lipids
Chronic Periodontitis D055113 1 associated lipids
Acute Coronary Syndrome D054058 11 associated lipids
Dengue D003715 2 associated lipids
Plaque, Atherosclerotic D058226 7 associated lipids
Systemic Inflammatory Response Syndrome D018746 4 associated lipids
Malnutrition D044342 6 associated lipids
Insulin Resistance D007333 99 associated lipids
Hemangioma, Capillary D018324 1 associated lipids
Neoplastic Syndromes, Hereditary D009386 1 associated lipids
Prenatal Exposure Delayed Effects D011297 2 associated lipids
Hot Flashes D019584 5 associated lipids
No-Reflow Phenomenon D054318 2 associated lipids
Vascular Calcification D061205 1 associated lipids
Peri-Implantitis D057873 1 associated lipids
Periodontal Attachment Loss D017622 7 associated lipids
Bone Cysts, Aneurysmal D017824 2 associated lipids
Diabetes Complications D048909 4 associated lipids
Pericardial Effusion D010490 2 associated lipids
Emphysema D004646 1 associated lipids
Pulmonary Disease, Chronic Obstructive D029424 16 associated lipids
Atrial Remodeling D064752 1 associated lipids
Hyperparathyroidism, Primary D049950 1 associated lipids
Lithiasis D020347 2 associated lipids
Osteoporotic Fractures D058866 1 associated lipids
Multiple Sclerosis, Chronic Progressive D020528 3 associated lipids
Per page 10 20 50 100 | Total 298

All references with 7-octadecynoic acid

Download all related citations
Per page 10 20 50 100 | Total 4091
Authors Title Published Journal PubMed Link
pmid:
Shalhoub V et al. Osteoprotegerin and osteoprotegerin ligand effects on osteoclast formation from human peripheral blood mononuclear cell precursors. 1999 J. Cell. Biochem. pmid:10022507
Hsu H et al. Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand. 1999 Proc. Natl. Acad. Sci. U.S.A. pmid:10097072
Nagai M and Sato N Reciprocal gene expression of osteoclastogenesis inhibitory factor and osteoclast differentiation factor regulates osteoclast formation. 1999 Biochem. Biophys. Res. Commun. pmid:10208850
Burgess TL et al. The ligand for osteoprotegerin (OPGL) directly activates mature osteoclasts. 1999 J. Cell Biol. pmid:10225954
Kong YY et al. Osteoprotegerin ligand: a common link between osteoclastogenesis, lymph node formation and lymphocyte development. 1999 Immunol. Cell Biol. pmid:10234557
Yano K et al. Immunological characterization of circulating osteoprotegerin/osteoclastogenesis inhibitory factor: increased serum concentrations in postmenopausal women with osteoporosis. 1999 J. Bone Miner. Res. pmid:10234572
Zhang XD et al. Relation of TNF-related apoptosis-inducing ligand (TRAIL) receptor and FLICE-inhibitory protein expression to TRAIL-induced apoptosis of melanoma. 1999 Cancer Res. pmid:10364001
Spelsberg TC et al. The actions and interactions of sex steroids and growth factors/cytokines on the skeleton. 1999 Mol. Endocrinol. pmid:10379881
Yasuda H et al. A novel molecular mechanism modulating osteoclast differentiation and function. 1999 Bone pmid:10423033
Roodman GD Cell biology of the osteoclast. 1999 Exp. Hematol. pmid:10428500
Lee SK and Lorenzo JA Parathyroid hormone stimulates TRANCE and inhibits osteoprotegerin messenger ribonucleic acid expression in murine bone marrow cultures: correlation with osteoclast-like cell formation. 1999 Endocrinology pmid:10433211
Ito H et al. Hedgehog signaling molecules in bone marrow cells at the initial stage of fracture repair. 1999 Biochem. Biophys. Res. Commun. pmid:10462495
Hofbauer LC et al. Estrogen stimulates gene expression and protein production of osteoprotegerin in human osteoblastic cells. 1999 Endocrinology pmid:10465311
Morony S et al. A chimeric form of osteoprotegerin inhibits hypercalcemia and bone resorption induced by IL-1beta, TNF-alpha, PTH, PTHrP, and 1, 25(OH)2D3. 1999 J. Bone Miner. Res. pmid:10469275
Sakata M et al. Expression of osteoprotegerin (osteoclastogenesis inhibitory factor) in cultures of human dental mesenchymal cells and epithelial cells. 1999 J. Bone Miner. Res. pmid:10469276
Lazner F et al. Osteopetrosis and osteoporosis: two sides of the same coin. 1999 Hum. Mol. Genet. pmid:10469835
Hofbauer LC Osteoprotegerin ligand and osteoprotegerin: novel implications for osteoclast biology and bone metabolism. 1999 Eur. J. Endocrinol. pmid:10474114
Wickelgren I Mining the genome for drugs. 1999 Science pmid:10475849
Hofbauer LC et al. Stimulation of osteoprotegerin ligand and inhibition of osteoprotegerin production by glucocorticoids in human osteoblastic lineage cells: potential paracrine mechanisms of glucocorticoid-induced osteoporosis. 1999 Endocrinology pmid:10499489
Thomas RJ et al. Breast cancer cells interact with osteoblasts to support osteoclast formation. 1999 Endocrinology pmid:10499498
Itonaga I et al. 1,25-Dihydroxyvitamin D(3) and prostaglandin E(2) act directly on circulating human osteoclast precursors. 1999 Biochem. Biophys. Res. Commun. pmid:10529407
Nakagawa N et al. Basic fibroblast growth factor inhibits osteoclast formation induced by 1alpha,25-dihydroxyvitamin D(3) through suppressing the production of osteoclast differentiation factor. 1999 Biochem. Biophys. Res. Commun. pmid:10548488
Nakagawa N et al. Basic fibroblast growth factor induces osteoclast formation by reciprocally regulating the production of osteoclast differentiation factor and osteoclastogenesis inhibitory factor in mouse osteoblastic cells. 1999 Biochem. Biophys. Res. Commun. pmid:10548507
Kong YY et al. Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. 1999 Nature pmid:10580503
Yamashita T et al. Retardation in bone resorption after bone marrow ablation in klotho mutant mice. 2000 Endocrinology pmid:10614667
Itonaga I et al. Effect of osteoprotegerin and osteoprotegerin ligand on osteoclast formation by arthroplasty membrane derived macrophages. 2000 Ann. Rheum. Dis. pmid:10627423
Chikatsu N et al. Interactions between cancer and bone marrow cells induce osteoclast differentiation factor expression and osteoclast-like cell formation in vitro. 2000 Biochem. Biophys. Res. Commun. pmid:10631114
Hofbauer LC et al. The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption. 2000 J. Bone Miner. Res. pmid:10646108
Tricot G New insights into role of microenvironment in multiple myeloma. 2000 Lancet pmid:10675068
Makhluf HA et al. Age-related decline in osteoprotegerin expression by human bone marrow cells cultured in three-dimensional collagen sponges. 2000 Biochem. Biophys. Res. Commun. pmid:10679262
Merewether LA et al. Development of disulfide peptide mapping and determination of disulfide structure of recombinant human osteoprotegerin chimera produced in Escherichia coli. 2000 Arch. Biochem. Biophys. pmid:10683254
Takayanagi H et al. Involvement of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis. 2000 Arthritis Rheum. pmid:10693864
Huang L et al. Gene expression of osteoprotegerin ligand, osteoprotegerin, and receptor activator of NF-kappaB in giant cell tumor of bone: possible involvement in tumor cell-induced osteoclast-like cell formation. 2000 Am. J. Pathol. pmid:10702390
Capparelli C et al. Osteoprotegerin prevents and reverses hypercalcemia in a murine model of humoral hypercalcemia of malignancy. 2000 Cancer Res. pmid:10706080
Ross FP RANKing the importance of measles virus in Paget's disease. 2000 J. Clin. Invest. pmid:10712423
Bateman TA et al. Osteoprotegerin mitigates tail suspension-induced osteopenia. 2000 Bone pmid:10773583
Mukohyama H et al. The inhibitory effects of vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide on osteoclast formation are associated with upregulation of osteoprotegerin and downregulation of RANKL and RANK. 2000 Biochem. Biophys. Res. Commun. pmid:10777696
Atkins GJ et al. Expression of osteoclast differentiation signals by stromal elements of giant cell tumors. 2000 J. Bone Miner. Res. pmid:10780856
Aubin JE and Bonnelye E Osteoprotegerin and its ligand: A new paradigm for regulation of osteoclastogenesis and bone resorption. 2000 Medscape Womens Health pmid:10792853
Thompson SW and Tonge D Bone cancer gain without the pain. 2000 Nat. Med. pmid:10802700
Honore P et al. Osteoprotegerin blocks bone cancer-induced skeletal destruction, skeletal pain and pain-related neurochemical reorganization of the spinal cord. 2000 Nat. Med. pmid:10802707
Onyia JE et al. In vivo demonstration that human parathyroid hormone 1-38 inhibits the expression of osteoprotegerin in bone with the kinetics of an immediate early gene. 2000 J. Bone Miner. Res. pmid:10804015
Malyankar UM et al. Osteoprotegerin is an alpha vbeta 3-induced, NF-kappa B-dependent survival factor for endothelial cells. 2000 J. Biol. Chem. pmid:10811631
Kanzawa M et al. Involvement of osteoprotegerin/osteoclastogenesis inhibitory factor in the stimulation of osteoclast formation by parathyroid hormone in mouse bone cells. 2000 Eur. J. Endocrinol. pmid:10822231
Thirunavukkarasu K et al. The osteoblast-specific transcription factor Cbfa1 contributes to the expression of osteoprotegerin, a potent inhibitor of osteoclast differentiation and function. 2000 J. Biol. Chem. pmid:10833509
Günther T and Schinke T Mouse genetics have uncovered new paradigms in bone biology. 2000 Trends Endocrinol. Metab. pmid:10856921
Rani CS and MacDougall M Dental cells express factors that regulate bone resorption. 2000 Mol. Cell Biol. Res. Commun. pmid:10860862
Tsurukai T et al. Roles of macrophage-colony stimulating factor and osteoclast differentiation factor in osteoclastogenesis. 2000 J. Bone Miner. Metab. pmid:10874596
Hofbauer LC and Heufelder AE Clinical review 114: hot topic. The role of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in the pathogenesis and treatment of metabolic bone diseases. 2000 J. Clin. Endocrinol. Metab. pmid:10902778

Table of Content